The Euro-Global Platformfor Mechanism-basedDrug Repurposing
From imprecise drug therapyto precision medicine
BIOINFORMATICS
In silico disease modelling
Virtual patient
Artificial Intelligence
De novo signalling module
construction
REPURPOSING
Network pharmacology
Reformulation
Freedom to operate
Patents & business
development
PRECISION DIAGNOSTICS
Redefining disease
Mechanism-based
Patient stratification
Focus on point of care
diagnostics
INNOVATIVE TRIALS
Low numbers, low costs, low risk
Patient-centric
Ethics-by-design
Focus on Investigator-Initiated
Trials
New disease definitions
Our disease definitions are updated. Most underlying disease mechanisms are not understood and are thus treated symptomatically in an imprecise manner
Organ-agnostic medicine
Chronic diseases are only chronic because we do not know how to cure them yet. Our organ-agnostic approach will push drug repurposing to its full potential
Network pharmacology
Unlocking the mechanisms governing a specific disease will allow us to repurpose drugs for another disease sharing some of those common elements
Precision medicine
Breakthroughs in precision, efficacy and cost-effectiveness will help de-risk drug repurposing and pave the way towards personalized therapies
Let's talk drug repurposing
REPO4EU is a EU-funded initiative that brings together 28 partners from 10 countries worldwide.
We have the experts and the experience to help you!